§ 314.630. Postmarketing safety reporting.
29 words·~1 min read·
/us/cfr/t21/s§ 314.630·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Drug products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting requirements applicable to all approved drug products, as provided in §§ 314.80 and 314.81.